Perchloropyridine

Catalog No.: 
ACXZNK987
CAS No.: 
2176-62-7
Molecular Formula: 
C5Cl5N
Molecular Weight: 
251.33
Perchloropyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
500g98%$61.00In stockInquiry
1000g98%$85.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePerchloropyridine
IUPAC Nameperchloropyridine
MDL No.MFCD00006230
Molecular FormulaC5Cl5N
Molecular Weight251.33
SMILESClC1=NC(Cl)=C(Cl)C(Cl)=C1Cl
InChI KeyDNDPLEAVNVOOQZ-UHFFFAOYSA-N
SynonymBRN 0155197 | C5CL5N_100K | A815655 | NSC 26286 | NCGC00254444-01 | SCHEMBL468366 | 2,3,4,5,6-Pentchloropyridine | P1661 | Pyridine, pentachloro- | C5CL5N_200K | D77706 | Pyridine,3,4,5,6-pentachloro- | 2,4,5,6-Pentachloropyridine | Pyridine, 2,3,4,5,6-pe
CAS No.2176-62-7
PubChem CID16584

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACXZNK987 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8In Stock
  2. Plus
  3. ACXZNK987 route compound structure diagram
    ACXZNK9872176-62-7In Stock
  4. Then
  5. ACXZNK987 route product structure diagram
    ACXZNK9872176-62-7In Stock
Inquiry

2. ACXZNK987 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXZNK987 route compound structure diagram
    ACXZNK9872176-62-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXZNK987 route product structure diagram
    ACXZNK9872176-62-7In Stock
Inquiry

3. ACXZNK987 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXZNK987 route product structure diagram
    ACXZNK9872176-62-7In Stock
Inquiry

Comments (0)